Keyword: cannabinoids

Cannabidiol might work as a powerful antibiotic against certain drug-resistant bacteria such as methicillin-resistant S. aureus.

Corbus bought over 600 compounds from Jenrin Discovery to fuel 1 to 2 new clinical programs in inflammatory and fibrotic diseases annually from 2020.

Auxly Cannabis Group is buying KGK in a cash and stock deal worth $12.3 million.

GB Sciences will soon start human testing of three cannabis-derived formulations for Parkinson's, chronic pain and cardiovascular diseases.

Axim Biotechnologies, which explores medical uses of cannabis, has decided to continue contracting Ora to manage its drug R&D activities and clinical trials on glaucoma and dry eye.

GW Pharma has clocked a third set of positive pivotal trial data, which makes it an even more attractive potential purchase.

GW Pharmaceuticals gained about $500 million in market cap on rumors that it may soon be acquired.